Drug:
Reaction: RASH
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940267 |
US |
82 | 1 |
Macule, Pruritus, Petechiae, Rash, |
||||
| 2 | 26940361 |
US |
2 | |
Adverse drug reaction, Rash, Fatigue, Headache, Needle issue, Needle issue, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CALCIUM, ERGOCALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN C, CYANOCOBALAMIN, BUPROPION, ALPRAZOLAM, SERTRALINE, |
||||
| 3 | 26940409 |
GB |
35 | 2 |
Flushing, Generalised oedema, Cold sweat, Headache, Swelling face, Dyspnoea, Dizziness, Vomiting, Peripheral swelling, Palmar erythema, Rash, |
||||
USTEKINUMAB, LANSOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SCOPOLAMINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MORPHINE SULFATE, |
||||
| 4 | 26940421 |
US |
62 | 2 |
Weight increased, Drug hypersensitivity, Rash, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 5 | 26940447 |
GB |
35 | 2 |
Swelling face, Rash, Rash, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 6 | 26940467 |
US |
2 | |
Dysgeusia, Headache, Rash, Vision blurred, Back pain, |
||||
ABALOPARATIDE, |
||||
| 7 | 26940478 |
US |
36 | 2 |
Eczema, Rash, |
||||
DUPILUMAB, |
||||
| 8 | 26940687 |
PR |
76 | 1 |
Back pain, Pharyngitis, Rash, Rhinitis allergic, |
||||
APALUTAMIDE, |
||||
| 9 | 26940768 |
EU |
63 | 1 |
Loss of consciousness, Rash, Erythema, |
||||
AMOXICILLIN, AMOXICILLIN AND CLAVULANATE POTASSIUM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 10 | 26940797 |
US |
85 | 2 |
Blood pressure abnormal, Rash, |
||||
DUPILUMAB, |
||||
| 11 | 26940806 |
US |
2 | |
Vascular injury, Peripheral swelling, Skin discolouration, Fatigue, Heart rate increased, Dizziness, Injection site pain, Pruritus, Rash, Arthralgia, Diarrhoea, Insomnia, |
||||
ABALOPARATIDE, |
||||
| 12 | 26940824 |
US |
74 | 2 |
Peripheral swelling, Pyrexia, Eye infection, Erythema, Swelling, Rash, |
||||
DUPILUMAB, |
||||
| 13 | 26940828 |
US |
20 | 2 |
Rash, |
||||
DUPILUMAB, |
||||
| 14 | 26940833 |
US |
1 | |
Rash, Swelling, Pruritus, |
||||
DUPILUMAB, |
||||
| 15 | 26940854 |
EU |
26 | 2 |
Pemphigoid, Autoimmune blistering disease, Pruritus, Blister, Rash, Erythema, Product use in unapproved indication, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 16 | 26940878 |
US |
2 | |
Rash, Constipation, Nausea, Diarrhoea, Abdominal pain upper, |
||||
TIRZEPATIDE, |
||||
| 17 | 26940915 |
US |
2 | |
Eye swelling, Fatigue, Rash, |
||||
ABALOPARATIDE, |
||||
| 18 | 26940950 |
US |
2 | |
Tongue blistering, Hepatic enzyme increased, Alanine aminotransferase increased, Rash, |
||||
ABALOPARATIDE, NAPROXEN, NAPROXEN SODIUM, |
||||
| 19 | 26940962 |
US |
2 | |
Gait disturbance, Muscle spasms, Rash, |
||||
ABALOPARATIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, CICLOPIROX, FLUTICASONE PROPIONATE, |
||||
| 20 | 26940990 |
US |
2 | |
Taste disorder, Weight decreased, Decreased appetite, Blood pressure increased, Nausea, Headache, Rash, Dizziness, Alopecia, Dry skin, |
||||
ABALOPARATIDE, |
||||
| 21 | 26941009 |
EU |
83 | 1 |
Neuropathy peripheral, Temperature intolerance, Skin erosion, Rash, |
||||
PREDNISONE, |
||||
| 22 | 26941152 |
41 | 1 | |
Rash, White blood cell count increased, Eosinophil count increased, Hepatic enzyme increased, Dermatitis, Off label use, |
||||
CEFOXITIN, CEFOXITIN SODIUM, OMADACYCLINE, LINEZOLID, |
||||
| 23 | 26941199 |
EU |
41 | 2 |
Febrile bone marrow aplasia, Pulmonary embolism, Neutropenia, Thrombocytopenia, Myalgia, Rash, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PEMBROLIZUMAB, |
||||
| 24 | 26941290 |
US |
2 | |
Sleep disorder, Discomfort, Sleep disorder due to a general medical condition, Rash, |
||||
DUPILUMAB, DUPILUMAB, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 25 | 26941293 |
CN |
64 | 1 |
Scabies, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 26 | 26941296 |
US |
2 | |
Heart rate increased, Rash, Diarrhoea, |
||||
TERIFLUNOMIDE, |
||||
| 27 | 26941314 |
US |
43 | 2 |
Eczema, Pruritus, Sleep disorder, Rash, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, RUXOLITINIB, |
||||
| 28 | 26941349 |
EU |
55 | 2 |
Rash, Pain, Cognitive disorder, Apathy, Asthenia, Decreased appetite, |
||||
OLANZAPINE, SERTRALINE HYDROCHLORIDE, |
||||
| 29 | 26941550 |
2 | ||
Rash erythematous, Rash, Rash papular, |
||||
OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, |
||||
| 30 | 26941655 |
US |
32 | 2 |
Rash, Rash pruritic, Chest discomfort, Erythema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 31 | 26941672 |
US |
63 | 2 |
Emotional disorder, Presyncope, Dyspnoea, Asthenia, Diarrhoea, Fatigue, Headache, Decreased appetite, Perioral dermatitis, Rash, |
||||
VANDETANIB, VENLAFAXINE HYDROCHLORIDE, |
||||
| 32 | 26941701 |
US |
2 | |
Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 33 | 26941716 |
US |
11 | 2 |
Rash, Pruritus, |
||||
DUPILUMAB, |
||||
| 34 | 26941814 |
US |
60 | 1 |
Rash, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 35 | 26941818 |
EU |
2 | |
Urinary retention, Nephrolithiasis, Myalgia, Rash, Palpitations, Infection, Alopecia, |
||||
NILOTINIB, NILOTINIB, |
||||
| 36 | 26941822 |
US |
2 | |
Petechiae, Rash, |
||||
ABALOPARATIDE, |
||||
| 37 | 26941872 |
CA |
53 | |
Cardiac murmur, Colitis ulcerative, Impaired quality of life, Pneumonia, Condition aggravated, Frequent bowel movements, Adverse drug reaction, Migraine, Blood cholesterol increased, Bronchiectasis, Hypopnoea, Pain in extremity, Rhinitis, Lymphocyte count decreased, Eczema, Parosmia, Steroid dependence, Abdominal discomfort, Gingival pain, Pulmonary embolism, Catarrh, COVID-19, Vertigo, Impaired work ability, Arthritis, Swollen tongue, Tubulointerstitial nephritis, Palpitations, Dysgeusia, Cerebrovascular accident, Nightmare, Pain, Deep vein thrombosis, Stress, Neutrophil count increased, Monocyte count decreased, C-reactive protein increased, Haemoglobin decreased, Platelet count increased, Haematocrit decreased, Haematochezia, Uterine leiomyoma, Gamma-glutamyltransferase increased, Red cell distribution width increased, Mean cell haemoglobin concentration decreased, Red blood cell count decreased, Mean platelet volume decreased, Depression, Systemic lupus erythematosus, Abdominal lymphadenopathy, Confusional state, Headache, Tinnitus, Somnolence, Rash, Hypersensitivity, Rectal haemorrhage, Pyrexia, Weight decreased, Burns second degree, Alcohol poisoning, Inappropriate schedule of product administration, Product use in unapproved indication, Off label use, Drug ineffective, Accidental overdose, Fatigue, |
||||
ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, OXYCODONE, OXYCODONE, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, PREDNISONE, PREDNISONE, PREDNISONE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ERGOCALCIFEROL, MESALAMINE, CALCIUM CARBONATE, ANTACID, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, EPINEPHRINE HYDROCHLORIDE, CANDESARTAN CILEXETIL, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, INFLIXIMAB-DYYB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, VEDOLIZUMAB, VEDOLIZUMAB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MESALAMINE, MESALAMINE, RAMIPRIL, PRAVASTATIN SODIUM, MESALAMINE, MESALAMINE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, INFLIXIMAB-DYYB, ERGOCALCIFEROL, FESOTERODINE FUMARATE, |
||||
| 38 | 26941963 |
US |
2 | |
Urticaria, Rash, |
||||
TIRZEPATIDE, |
||||
| 39 | 26942044 |
US |
1 | |
Rash, |
||||
PIMAVANSERIN TARTRATE, QUETIAPINE, |
||||
| 40 | 26942125 |
US |
7 | 2 |
Condition aggravated, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 41 | 26942183 |
US |
36 | 2 |
Rash, Abdominal discomfort, Nausea, |
||||
BELIMUMAB, VOCLOSPORIN, |
||||
| 42 | 26942443 |
US |
1 | |
Rash, Discomfort, Sleep disorder due to a general medical condition, Rash macular, Dermatitis atopic, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 43 | 26942482 |
US |
64 | 2 |
Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 44 | 26942537 |
CA |
75 | 2 |
Hepatotoxicity, Off label use, Abdominal discomfort, Rash, Drug ineffective, Drug ineffective, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, UPADACITINIB, DIFLUPREDNATE OPHTHALMIC, DIFLUPREDNATE, |
||||
| 45 | 26942753 |
US |
72 | 1 |
Rash, Dry skin, Pruritus, Inappropriate schedule of product administration, Periorbital swelling, Therapy cessation, Eye discharge, |
||||
IVERMECTIN, |
||||
| 46 | 26942788 |
US |
2 | |
Hypersensitivity, Swelling face, Rash, |
||||
IVERMECTIN, |
||||
| 47 | 26942847 |
US |
1 | 1 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 48 | 26942925 |
US |
1 | |
Rash, |
||||
EVOLOCUMAB, |
||||
| 49 | 26943057 |
CA |
||
Drug ineffective, Pain in extremity, Wound, Injection site irritation, Injection site erythema, Urticaria, Blood immunoglobulin G increased, Injection site pruritus, Peripheral swelling, Gastrointestinal disorder, Impaired healing, Injection site pain, Blood immunoglobulin G decreased, Illness, Discomfort, Rash, Fear of injection, |
||||
PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, HUMAN IMMUNOGLOBULIN G, PRAZOSIN HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, MORPHINE SULFATE, MORPHINE SULFATE, PREGABALIN, DIMENHYDRINATE, SERTRALINE HYDROCHLORIDE, SUMATRIPTAN SUCCINATE, |
||||
| 50 | 26943090 |
US |
56 | 2 |
Diarrhoea, Rash, |
||||
TUCATINIB, |
||||
| 51 | 26943103 |
US |
71 | 2 |
Dementia, Expired product administered, Rash, Ill-defined disorder, COVID-19, |
||||
ETANERCEPT, |
||||
| 52 | 26943112 |
CA |
44 | 2 |
Breast cancer stage III, Folliculitis, Sciatica, Hypoaesthesia, Memory impairment, Dyspepsia, Taste disorder, Crohn^s disease, Bone erosion, Gait inability, Gastrooesophageal reflux disease, Pneumonia, Decreased appetite, Insomnia, Disability, Confusional state, Grip strength decreased, Sleep disorder due to a general medical condition, Product use in unapproved indication, Blister, Adjustment disorder with depressed mood, Dislocation of vertebra, Hypercholesterolaemia, Lip dry, Blepharospasm, Systemic lupus erythematosus, Therapeutic product effect decreased, Anxiety, Delirium, Impaired healing, Infusion site reaction, Malaise, Bursitis, Facet joint syndrome, Lower respiratory tract infection, Dyspnoea, Drug intolerance, Prescribed overdose, Helicobacter infection, Dizziness, Sleep disorder, Rash, Glossodynia, C-reactive protein increased, Ulcer haemorrhage, Incorrect route of product administration, Therapeutic product effect incomplete, Maternal exposure during pregnancy, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Respiratory disorder, Psoriatic arthropathy, Urticaria, Depression, Contusion, Hepatic cirrhosis, Product quality issue, Hypersensitivity, Blood cholesterol increased, Drug hypersensitivity, Sinusitis, Exostosis, Discomfort, Deep vein thrombosis postoperative, Intentional product use issue, Condition aggravated, Diarrhoea, Hand deformity, Gait disturbance, Lower limb fracture, X-ray abnormal, Pericarditis, Stomatitis, Back injury, Duodenal ulcer perforation, Lupus-like syndrome, Ear pain, Ill-defined disorder, Alopecia, Fatigue, Synovitis, Type 2 diabetes mellitus, Prescribed underdose, Exposure during pregnancy, Rheumatoid factor positive, Product use issue, Epilepsy, Rheumatoid arthritis, Gastrointestinal disorder, Swollen joint count increased, Red blood cell sedimentation rate increased, Treatment failure, Irritable bowel syndrome, Contraindicated product administered, Swelling, Hypertension, Breast cancer stage II, Laryngitis, Drug ineffective, Pyrexia, Asthenia, Headache, Medication error, General physical health deterioration, Asthma, Therapy non-responder, Hepatic enzyme increased, Chest pain, Rheumatic fever, Drug tolerance, Fibromyalgia, Dry mouth, Peripheral swelling, Infusion related reaction, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, INFLIXIMAB, ABATACEPT, OXYCODONE, OXYCODONE, CELECOXIB, CELECOXIB, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, SECUKINUMAB, MEPOLIZUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CELECOXIB, CELECOXIB, RAMIPRIL, RAMIPRIL, LAMOTRIGINE, LAMOTRIGINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, |
||||
| 53 | 26943134 |
JP |
1 | |
Neuropathy peripheral, Rash, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 54 | 26943176 |
EG |
40 | 1 |
Gastric ulcer, Subcutaneous abscess, Pruritus, Acne, Rash, Glossitis, Diarrhoea, Fatigue, Vomiting, Bedridden, |
||||
PANITUMUMAB, FILGRASTIM, ATROPINE SULFATE, ATROPINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 55 | 26943239 |
US |
2 | |
Rash, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 56 | 26943252 |
US |
60 | 2 |
Myalgia, Muscular weakness, Gait disturbance, Rash, Arthralgia, |
||||
DUPILUMAB, |
||||
| 57 | 26943263 |
US |
3 | 1 |
Therapeutic response shortened, Dermatitis atopic, Sleep disorder due to a general medical condition, Irritability, Rash, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CETIRIZINE HCL, CETIRIZINE, |
||||
| 58 | 26943264 |
US |
1 | |
Rash, Pruritus, |
||||
DUPILUMAB, |
||||
| 59 | 26943324 |
US |
77 | 2 |
Rash, Infection, |
||||
INSULIN ASPART, |
||||
| 60 | 26943387 |
TW |
64 | 2 |
Lung adenocarcinoma stage IV, Malignant neoplasm progression, Diarrhoea, Decreased appetite, Rash, Mucosal inflammation, Swelling of eyelid, Off label use, |
||||
TRAMETINIB, TRAMETINIB, TRAMETINIB, TRAMETINIB, GEFITINIB, GEFITINIB, |
||||
| 61 | 26943487 |
US |
59 | 1 |
Loss of consciousness, Skin exfoliation, Drug ineffective, Arthralgia, Pain in extremity, Fingerprint loss, Skin erosion, Headache, Rash, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 62 | 26943502 |
EG |
18 | 2 |
Systemic lupus erythematosus, Systemic lupus erythematosus, Rash, Rash, Pain, Pain, Pyrexia, Pyrexia, |
||||
UPADACITINIB, |
||||
| 63 | 26943595 |
US |
87 | 2 |
Rash, |
||||
DUPILUMAB, |
||||
| 64 | 26943602 |
GB |
38 | 2 |
Basal cell carcinoma, Hyperthyroidism, Headache, Rash, Chest discomfort, Restless legs syndrome, Gastrooesophageal reflux disease, Palpitations, Dysaesthesia, Neuralgia, Non-cardiac chest pain, Dizziness, |
||||
ALEMTUZUMAB, ALEMTUZUMAB, ALEMTUZUMAB, ACYCLOVIR, ACYCLOVIR, ACYCLOVIR, AMOXICILLIN, AMOXICILLIN, GABAPENTIN, METHYLPREDNISOLONE, CHLORPHENIRAMINE MALEATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 65 | 26943623 |
US |
28 | 2 |
Skin exfoliation, Rash, Skin fissures, |
||||
DUPILUMAB, |
||||
| 66 | 26943633 |
US |
2 | |
Skin haemorrhage, Rash, |
||||
DUPILUMAB, |
||||
| 67 | 26943674 |
US |
74 | |
Rash, Pruritus, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 68 | 26943691 |
US |
51 | |
Rash, Device defective, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 69 | 26944186 |
US |
2 | |
Rash, |
||||
DUPILUMAB, |
||||
| 70 | 26944241 |
US |
2 | |
Urticaria, Rash, |
||||
MICONAZOLE NITRATE, MICONAZOLE NITRATE, |
||||
| 71 | 26944297 |
US |
2 | |
Rash, |
||||
MICONAZOLE NITRATE, MICONAZOLE NITRATE, |
||||
| 72 | 26944312 |
EU |
41 | 2 |
Febrile bone marrow aplasia, Neutropenia, Pulmonary embolism, Thrombocytopenia, Myalgia, Rash, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, PEMBROLIZUMAB, |
||||
| 73 | 26944315 |
US |
77 | 1 |
Chest discomfort, Rash, |
||||
MEPOLIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST, CARVEDILOL, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 74 | 26944323 |
US |
53 | 1 |
Dizziness, Rash, Fatigue, |
||||
VEDOLIZUMAB, |
||||
| 75 | 26944325 |
US |
1 | |
Rash, |
||||
VEDOLIZUMAB, |
||||
| 76 | 26944418 |
US |
81 | 1 |
Rash, Peripheral swelling, |
||||
PIMAVANSERIN TARTRATE, INSULIN DEGLUDEC, |
||||
| 77 | 26944451 |
US |
71 | 2 |
Rash, Pruritus, |
||||
| 78 | 26944457 |
US |
38 | 2 |
Rash, |
||||
| 79 | 26944554 |
US |
1 | |
Malignant neoplasm progression, Abdominal discomfort, Rash, Nausea, |
||||
| 80 | 26944580 |
US |
75 | 1 |
Rash, |
||||
SARILUMAB, |
||||
| 81 | 26944581 |
US |
18 | 1 |
Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 82 | 26944666 |
US |
32 | 1 |
Rash, Pyrexia, Hyperhidrosis, |
||||
SPARSENTAN, |
||||
| 83 | 26944844 |
US |
1 | |
Herpes zoster, Rash, Off label use, Product dose omission issue, Head discomfort, Headache, Ocular discomfort, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 84 | 26944912 |
US |
41 | 1 |
Drug reaction with eosinophilia and systemic symptoms, Hepatic enzyme increased, White blood cell count increased, Eosinophil count increased, Papule, Blister, Dermatitis, Rash, Erythema, Suspected off label use, |
||||
LINEZOLID, LINEZOLID, LINEZOLID, CEFOXITIN SODIUM, CEFOXITIN SODIUM, CEFOXITIN SODIUM, OMADACYCLINE, OMADACYCLINE, OMADACYCLINE, |
||||
| 85 | 26944922 |
US |
71 | |
Fluid retention, Weight increased, Heat stroke, Rash, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 86 | 26944980 |
US |
73 | 2 |
Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 87 | 26945027 |
US |
74 | 2 |
Chills, Pyrexia, Eczema, Headache, Injection site pain, Rash, Injection site reaction, |
||||
ABALOPARATIDE, ABALOPARATIDE, CALCIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, POLYETHYLENE GLYCOL 3350, FAMOTIDINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 88 | 26945036 |
US |
2 | |
Fear, Adverse reaction, Rash, Pruritus, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 89 | 26945262 |
US |
69 | |
Neurodermatitis, Rash, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 90 | 26945279 |
US |
2 | |
Diplopia, Rash vesicular, Blood blister, Rash, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 91 | 26945305 |
US |
65 | |
Rash, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, AMLODIPINE, PREDNISONE, |
||||
| 92 | 26945309 |
US |
2 | |
Cough, Rash, |
||||
ABALOPARATIDE, UPADACITINIB, CELECOXIB, DULOXETINE HYDROCHLORIDE, IRON, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYCHLOROQUINE SULFATE, TOFACITINIB, |
||||
| 93 | 26945428 |
US |
2 | |
Rash, |
||||
TOCILIZUMAB-AAZG, |
||||
| 94 | 26945471 |
US |
23 | 2 |
Eczema, Rash erythematous, Rash, Rash pruritic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 95 | 26945656 |
US |
2 | |
General symptom, Discomfort, Rash, |
||||
ESCITALOPRAM, |
||||
| 96 | 26945676 |
GB |
78 | 1 |
Myalgia, Rash, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EZETIMIBE, LANSOPRAZOLE, RAMIPRIL, ROSUVASTATIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ISOSORBIDE MONONITRATE, BISOPROLOL FUMARATE, |
||||
| 97 | 26945716 |
US |
75 | 2 |
Rash, |
||||
TIRZEPATIDE, TREPROSTINIL, |
||||
| 98 | 26945837 |
US |
2 | |
Weight increased, Anaemia, Abdominal distension, Rash, Bone pain, |
||||
ABALOPARATIDE, IRON, |
||||
| 99 | 26945858 |
CA |
57 | 2 |
Loss of consciousness, Neuralgia, Dermatitis, Skin lesion, Pain, Skin burning sensation, Pain in extremity, Mobility decreased, Gait disturbance, Condition aggravated, Rash, Dermatitis atopic, Blister, Pain, Skin fissures, Peripheral swelling, Skin hypertrophy, Electric shock sensation, |
||||
DUPILUMAB, DUPILUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AMLODIPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 100 | 26945902 |
GB |
63 | 1 |
Open globe injury, Rash, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
